Detalhe da pesquisa
1.
Pseudomonas aeruginosa pulmonary infection results in S100A8/A9-dependent cardiac dysfunction.
PLoS Pathog
; 19(8): e1011573, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37624851
2.
Novel bacterial topoisomerase inhibitors: unique targeting activities of amide enzyme-binding motifs for tricyclic analogs.
Antimicrob Agents Chemother
; 67(10): e0048223, 2023 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37724886
3.
Pseudomonas aeruginosa rugose small-colony variants evade host clearance, are hyper-inflammatory, and persist in multiple host environments.
PLoS Pathog
; 14(2): e1006842, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29394295
4.
Treatment with the Pseudomonas aeruginosa Glycoside Hydrolase PslG Combats Wound Infection by Improving Antibiotic Efficacy and Host Innate Immune Activity.
Antimicrob Agents Chemother
; 63(6)2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30988141
5.
Synthesis and anti-staphylococcal activity of novel bacterial topoisomerase inhibitors with a 5-amino-1,3-dioxane linker moiety.
Bioorg Med Chem Lett
; 28(14): 2477-2480, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29871847
6.
The transcription factor AmrZ utilizes multiple DNA binding modes to recognize activator and repressor sequences of Pseudomonas aeruginosa virulence genes.
PLoS Pathog
; 8(4): e1002648, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22511872
7.
Dioxane-Linked Novel Bacterial Topoisomerase Inhibitors Exhibit Bactericidal Activity against Planktonic and Biofilm Staphylococcus aureus In Vitro.
Microbiol Spectr
; 10(6): e0205622, 2022 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36250857
8.
Novel bacterial topoisomerase inhibitors derived from isomannide.
Eur J Med Chem
; 199: 112324, 2020 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32402932
9.
Mucin glycans attenuate the virulence of Pseudomonas aeruginosa in infection.
Nat Microbiol
; 4(12): 2146-2154, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31611643